ID

22920

Beschrijving

Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).; ODM derived from: https://clinicaltrials.gov/show/NCT00337779

Link

https://clinicaltrials.gov/show/NCT00337779

Trefwoorden

Versies (1)
  1. 16-06-17 16-06-17 -
Geüploaded op

16 juni 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Relapsing Remitting Multiple Sclerosis NCT00337779

Engels

Eligibility Relapsing Remitting Multiple Sclerosis NCT00337779

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. diagnosis of confirmed and documented ms defined by the revised mcdonald criteria.
Beschrijving

Multiple Sclerosis

Datatype

boolean

Alias
UMLS CUI [1]
C0026769
2. subjects must be of the relapsing-remitting (r-r) type.
Beschrijving

Multiple Sclerosis, Relapsing-Remitting

Datatype

boolean

Alias
UMLS CUI [1]
C0751967
3. subject has experienced prior to screening at least one documented relapse in 12 months or at least 2 documented relapses in the 24 months or one documented relapse between 12 - 24 months with at least 1 documented t1-gd enhancing lesion in the mri performed 12 months prior screening.
Beschrijving

Relapse Quantity | Gadolinium-Enhancing Lesion Quantity Magnetic Resonance Imaging

Datatype

boolean

Alias
UMLS CUI [1,1]
C0035020
UMLS CUI [1,2]
C1265611
UMLS CUI [2,1]
C1333400
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0024485
4. disease duration for at least 6 months.
Beschrijving

disease length

Datatype

boolean

Alias
UMLS CUI [1]
C0872146
5. ambulatory with converted kurtzke edss score of 0 - 5.
Beschrijving

Ambulatory Kurtzke multiple sclerosis rating scale

Datatype

boolean

Alias
UMLS CUI [1,1]
C0439841
UMLS CUI [1,2]
C0451246
6. relapse free and stable neurological condition at least for 30 days prior screening.
Beschrijving

Condition Neurologic Stable | Relapse Free of

Datatype

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0205494
UMLS CUI [1,3]
C0205360
UMLS CUI [2,1]
C0035020
UMLS CUI [2,2]
C0332296
7. age - 18-55 (inclusive)
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. previous use of copaxone (glatiramer acetate)
Beschrijving

Copaxone | glatiramer acetate

Datatype

boolean

Alias
UMLS CUI [1]
C0528175
UMLS CUI [2]
C0289884
2. treatment with corticosteroids within 30 days prior screening or between screening and baseline.
Beschrijving

Adrenal Cortex Hormones

Datatype

boolean

Alias
UMLS CUI [1]
C0001617
3. chronic corticosteroids treatment - more than 30 consecutive days.
Beschrijving

Adrenal Cortex Hormones chronic

Datatype

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0205191
4. subject with any clinically significant or unstable medical condition.
Beschrijving

Medical condition Clinical Significance | Medical condition Unstable

Datatype

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C2826293
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0443343
5. subjects participating in any other clinical trial (within 12 weeks prior to screening and thereafter).
Beschrijving

Study Subject Participation Status

Datatype

boolean

Alias
UMLS CUI [1]
C2348568
6. known history of sensitivity to gadolinium and inability to successfully undergo mri scanning.
Beschrijving

Hypersensitivity Gadolinium | Magnetic Resonance Imaging Receive Unable

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0016911
UMLS CUI [2,1]
C0024485
UMLS CUI [2,2]
C1514756
UMLS CUI [2,3]
C1299582
Terug naar het begin van de pagina

Similar models

Eligibility Relapsing Remitting Multiple Sclerosis NCT00337779

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Multiple Sclerosis
Item
1. diagnosis of confirmed and documented ms defined by the revised mcdonald criteria.
boolean
C0026769 (UMLS CUI [1])
Multiple Sclerosis, Relapsing-Remitting
Item
2. subjects must be of the relapsing-remitting (r-r) type.
boolean
C0751967 (UMLS CUI [1])
Relapse Quantity | Gadolinium-Enhancing Lesion Quantity Magnetic Resonance Imaging
Item
3. subject has experienced prior to screening at least one documented relapse in 12 months or at least 2 documented relapses in the 24 months or one documented relapse between 12 - 24 months with at least 1 documented t1-gd enhancing lesion in the mri performed 12 months prior screening.
boolean
C0035020 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1333400 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0024485 (UMLS CUI [2,3])
disease length
Item
4. disease duration for at least 6 months.
boolean
C0872146 (UMLS CUI [1])
Ambulatory Kurtzke multiple sclerosis rating scale
Item
5. ambulatory with converted kurtzke edss score of 0 - 5.
boolean
C0439841 (UMLS CUI [1,1])
C0451246 (UMLS CUI [1,2])
Condition Neurologic Stable | Relapse Free of
Item
6. relapse free and stable neurological condition at least for 30 days prior screening.
boolean
C0348080 (UMLS CUI [1,1])
C0205494 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0035020 (UMLS CUI [2,1])
C0332296 (UMLS CUI [2,2])
Age
Item
7. age - 18-55 (inclusive)
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Copaxone | glatiramer acetate
Item
1. previous use of copaxone (glatiramer acetate)
boolean
C0528175 (UMLS CUI [1])
C0289884 (UMLS CUI [2])
Adrenal Cortex Hormones
Item
2. treatment with corticosteroids within 30 days prior screening or between screening and baseline.
boolean
C0001617 (UMLS CUI [1])
Adrenal Cortex Hormones chronic
Item
3. chronic corticosteroids treatment - more than 30 consecutive days.
boolean
C0001617 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
Medical condition Clinical Significance | Medical condition Unstable
Item
4. subject with any clinically significant or unstable medical condition.
boolean
C3843040 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
Study Subject Participation Status
Item
5. subjects participating in any other clinical trial (within 12 weeks prior to screening and thereafter).
boolean
C2348568 (UMLS CUI [1])
Hypersensitivity Gadolinium | Magnetic Resonance Imaging Receive Unable
Item
6. known history of sensitivity to gadolinium and inability to successfully undergo mri scanning.
boolean
C0020517 (UMLS CUI [1,1])
C0016911 (UMLS CUI [1,2])
C0024485 (UMLS CUI [2,1])
C1514756 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial